Skip to main content
Clinical Trials/NCT06432829
NCT06432829
Not yet recruiting
Not Applicable

Study on the Efficacy and Differential Usability of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Spanish University Students

Instituto de Investigación Sanitaria Aragón1 site in 1 country70 target enrollmentJune 15, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Emotional Disorder
Sponsor
Instituto de Investigación Sanitaria Aragón
Enrollment
70
Locations
1
Primary Endpoint
Structured interview for anxiety disorders and related disorders, according to the DSM-5 (ADIS-5; Brown & Barlow, 2014)
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

The present study seeks to compare and analyze the degree of usefulness, acceptability and implementation of the Unified Protocol (UP) in its application in two cost-effective formats, the online group and the blended online group for the treatment of emotional disorders in university students in Spain.

Detailed Description

Introduction: Emotional Disorders (EDs) are the most common disorders among the young population. Despite their high prevalence in university students, data suggest that only 16.4% of students suffering from a mental health disorder receive treatment. Therefore, the present study seeks to compare and analyze the degree of usefulness, acceptability and implementation of the Unified Protocol (UP) in its application in two cost-effective formats, the online group and the Blended online group. Method: The study population will be university students who meet diagnostic criteria for EDs. We estimate a sample of 70 students, 35 per condition. The intervention will consist of the application of the 8 modules of the UP in two formats: online group format of 8 weekly sessions of 2 hours duration and Blended format (4 online group sessions, of two hours duration in modules 1,4,6 and 7 of the UP + autonomous work through the UP-APP). The variables evaluated will be collected before the intervention, in the post-treatment and in the follow-ups at one month and 3 months. This study responds to the need to implement services that improve the availability and access to the treatment of EDs in the university context in Spain, and in this particular case, through the formats offered by a transdiagnostic intervention such as the UP.

Registry
clinicaltrials.gov
Start Date
June 15, 2024
End Date
September 15, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Instituto de Investigación Sanitaria Aragón
Responsible Party
Principal Investigator
Principal Investigator

Jorge Javier Osma López

Principal Investigator

Instituto de Investigación Sanitaria Aragón

Eligibility Criteria

Inclusion Criteria

  • Be enrolled at the University of Cordoba (Spain), in any of the degrees
  • Have a diagnosis of anxiety or mood disorder from the Structured Interview for Anxiety and Related Disorders, according to the DSM-5 (ADIS-5)\*
  • Be at least 18 years old
  • Be fluent in the Spanish language
  • Have a technological device (Computer, Tablet, cell phone) with internet connection
  • Have a smartphone device with Android operating system
  • In the case of taking pharmacological treatment for the treatment of their ED, maintenance of the same doses and medications for at least 3 months before starting their participation in the study and throughout the treatment
  • Signature of the informed consent

Exclusion Criteria

  • Have a diagnosis of Obsessive Compulsive Disorder or Post Traumatic Stress Disorder
  • Have a severe condition that requires priority for treatment will not be able to participate in the study. This includes a serious mental disorder (personality disorder, schizophrenia, or an organic mental disorder), suicide risk at the time of assessment, or substance abuse within the past three months.

Outcomes

Primary Outcomes

Structured interview for anxiety disorders and related disorders, according to the DSM-5 (ADIS-5; Brown & Barlow, 2014)

Time Frame: Only before of the treatment to check inclusion criteria

Diagnostic interview to determine if the participant has a clinical diagnosis of emotional disorder (ET) and can be part of the study. The following diagnoses according to the DSM-V are included within the category of emotional disorder: major depressive disorder, dysthymic disorder, panic disorder, agoraphobia, obsessive-compulsive disorder, generalized anxiety disorder, post-traumatic stress disorder, social anxiety disorder, hypochondria, and adjustment disorders. Patients with anxiety disorders not otherwise specified and those with depressive disorders not otherwise specified will also be included in the study.

General Severity and Interference Scale for Anxiety (OASIS; Norman et al., 2006. Validated in Spanish by Osma et al., 2019)

Time Frame: Up to 3 months follow-up

Evaluation through 5 items of the frequency, intensity, severity and interference of anxious symptomatology

Questionnaire on Sociodemographic Data (ad hoc)

Time Frame: Pre-treatment data

Information will be collected on sex, age, marital status, employment status, type of study (bachelor's degree; postgraduate: master's degree, continuing education courses; doctorate), degree taken and course in which you are enrolled.

General Depression Severity and Interference Scale (ODSIS; Bentley et al., 2014. Validated in Spanish by Osma et al., 2019)

Time Frame: Up to 3 months follow-up

Evaluation through 5 items of the frequency, intensity, severity and interference of depressive symptomatology

Multidimensional Inventory for Emotional Disorders (MEDI; Rosellini and Brown, 2019. Validated in Spanish by Osma et al., 2023)

Time Frame: Up to 3 months follow-up

Evaluation through 49 items of the transdiagnostic profile of Emotional Disorders, which is composed of nine dimensions: neurotic temperament, positive temperament, depressed mood, somatic anxiety, arousal activation, social anxiety, intrusive cognitions, traumatic re-experiencing, and avoidance

Secondary Outcomes

  • EuroQol (Brooks, 1996. Validated in Spanish by Badia et al., 1999)(Up to 3 months follow-up)
  • Emotional Regulation Questionnaire (ERQ; Gross & John, 2003. Validated in Spanish by Pineda et al., 2018)(Up to 3 months follow-up)
  • Maladjustment Scale (EI; Echeburua; 2000; Validated in Spanish by Quiléz-Orden et al., in press)(Up to 3 months follow-up)
  • An adaptation of Client Satisfaction Questionnaire (CSQ-8) of Larsen et al., 1979(Up to 3 months follow-up)
  • Emotional Regulation Difficulties Scale (DERS; Gratz and Roemer, 2004. Validated in Spanish by Hervás & Jódar, 2008)(Up to 3 months follow-up)
  • Short Version of the Five Facets of Mindfulness Questionnaire (FFMQ-SF; Bohlmeijer et al., 2011. Validated in Spanish by Asensio-Martínez et al., 2019)(Up to 3 months follow-up)
  • System Usability Scale (SUS; Brooke, 1996. Validated in Spanish by Sevilla-Gonzalez et al., 2020)(Up to 3 months follow-up)
  • Short-format Therapeutic Alliance Inventory (WAI-S; Hatcher and Gillas, 2006. Validated in Spanish by Corbella et al., 2011)(Up to 3 months follow-up)
  • Evaluation questionnaire of the PU modules (Ad hoc)(Up to 3 months follow-up)

Study Sites (1)

Loading locations...

Similar Trials